封面
市场调查报告书
商品编码
1455402

2024 年生物工程技术世界市场报告

Bioengineering Technology Global Market Report 2024

出版日期: 按订单生产 | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10个工作天内

价格
简介目录

预计未来几年生物工程技术市场规模将快速成长。预计到 2028 年将以 13.0% 的复合年增长率 (CAGR) 增长至 5,219.8 亿美元。预测期内的预期增长可归因于对细胞疗法的日益关注、合成生物学的快速增长、精准医学的进步、农业应用的扩大以及环境解决方案的使用的扩大。预测期内预计的主要趋势包括先进的基因编辑技术、技术融合、精准医学的进一步进步、全球合作与伙伴关係、合成生物学应用等。

慢性病盛行率的上升预计将推动未来生物工程技术市场的扩张。慢性病的特征是长期、持续,并导致长期的健康状况。生物工程技术在慢性病的管理和治疗中发挥着重要作用,因为它们有潜力提供创新的解决方案、增强治疗效果并改善患者的生活品质。例如,国家生物技术资讯中心2023年1月报告称,慢性病患者预计将从2020年的7,152.2万人增加到2050年的1.4266亿人,成长99.5%。因此,慢性病盛行率的增加正在推动生物工程技术市场的成长。

生物工程技术市场的主要企业正专注于开发Mito Plus等创新技术产品,以推动再生医学领域的发展。 Mito Plus 是一款最先进的 3D 生物列印机,旨在使用 3D 列印技术来生产类似于自然身体部位(包括活细胞)的组织和器官。例如,印度 3D 列印机製造和服务供应商Avay Biosciences Pvt. Mito Plus 于 2022 年 11 月推出了 Mito Plus。这款最先进的生物印表机被誉为同价格分布中最先进的生物印表机之一,能够列印多种应用。它使用生物材料并具有内建的紫外线固化选项。它还具有内建 HEPA 过滤器和温度控制功能,除了加热功能外,还可让您将列印头和列印床冷却高达 4°C。

目录

第一章执行摘要

第二章 市场特点

第三章 市场趋势与策略

第四章宏观经济情景

  • 高通膨对市场的影响
  • 乌克兰与俄罗斯战争对市场的影响
  • COVID-19 对市场的影响

第五章世界市场规模与成长

  • 全球市场驱动因素与限制因素
    • 市场驱动因素
    • 市场限制因素
  • 2018-2023 年全球市场规模表现与成长
  • 全球市场规模预测与成长,2023-2028、2033

第六章市场区隔

  • 全球生物工程技术市场,依产品、绩效及预测细分,2018-2023、2023-2028、2033
  • 生物医学工程
  • 基因工程
  • 生物技术
  • 人体组织工程
  • 生物力学工程
  • 生物材料
  • 生物力学工程
  • 奈米生物技术
  • 生物资讯学
  • 其他产品
  • 全球生物工程技术市场,依技术、绩效及预测细分,2018-2023、2023-2028、2033
  • 奈米生物技术
  • 组织工程和再生
  • DNA序列测定
  • 基于细胞的检测
  • 发酵
  • 全球生物工程技术市场,按应用细分、实际和预测,2018-2023、2023-2028、2033
  • 健康
  • 粮食和农业
  • 自然资源与环境

第 7 章 区域与国家分析

  • 全球生物工程技术市场,按地区、绩效和预测,2018-2023、2023-2028、2033
  • 全球生物工程技术市场,按国家、绩效和预测,2018-2023、2023-2028、2033

第八章亚太市场

第九章 中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第14章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章 德国市场

第十八章 法国市场

第十九章 义大利市场

第20章 西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章加拿大市场

第26章 南美洲市场

第27章 巴西市场

第28章 中东市场

第29章 非洲市场

第三十章 竞争格局及公司概况

  • 生物工程技术市场竞争格局
  • 生物工程技术市场公司概况
    • Pfizer Inc.
    • Johnson &Johnson
    • Roche Holding AG
    • Novartis AG
    • Bristol-Myers Squibb Company

第三十一章 其他重大及创新企业

  • Thermo Fisher Scientific
  • Abbott Laboratories
  • AstraZeneca plc
  • Medtronic plc
  • Gilead Sciences Inc.
  • Amgen Inc.
  • Novo Nordisk A/S
  • Moderna Inc.
  • Becton Dickinson(BD)
  • Regeneron Pharmaceuticals, Inc.
  • Biogen Inc.
  • Vertex Pharmaceuticals Inc.
  • Agilent Technologies
  • Lonza Group Ltd.
  • Intuitive Surgical

第32章竞争基准化分析

第 33 章. 竞争对手仪表板

第三十四章 重大併购

第35章 未来前景与可能性分析

第36章附录

简介目录
Product Code: r16403

Bioengineering technology involves applying principles and techniques from engineering and the natural sciences to develop technologies and solutions for understanding, manipulating, and utilizing biological systems, particularly in the fields of medicine, biology, and healthcare.

The primary types of products in bioengineering technology include biomedical engineering, genetic engineering, biotechnology, tissue engineering, biomechanics engineering, biomaterials, nano-biotechnology, bioinformatics, and others. Biomedical engineering entails applying engineering principles and design concepts to medicine and biology for healthcare purposes. It encompasses various technologies such as nanobiotechnology, tissue engineering and regeneration, DNA sequencing, cell-based assays, and fermentation, and finds applications in health, food and agriculture, natural resources, and the environment.

The bioengineering technology market research report is one of a series of new reports from The Business Research Company that provides bioengineering technology market statistics, including bioengineering technology industry global market size, regional shares, competitors with a bioengineering technology market share, detailed bioengineering technology market segments, market trends and opportunities, and any further data you may need to thrive in the bioengineering technology industry. This bioengineering technology market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The bioengineering technology market size has grown rapidly in recent years. It will grow from $282.19 billion in 2023 to $320.38 billion in 2024 at a compound annual growth rate (CAGR) of 13.5%. The growth observed during the historic period can be attributed to several factors, including the increasing aging population, rising prevalence of chronic diseases, growth in the bioengineering technology market, favorable government initiatives, and the adoption of genetic engineering strategies.

The bioengineering technology market size is expected to see rapid growth in the next few years. It will grow to $521.98 billion in 2028 at a compound annual growth rate (CAGR) of 13.0%. The projected growth in the forecast period can be attributed to an increased focus on cell therapies, the rapid growth of synthetic biology, advancements in precision medicine, a growing application in agriculture, and an expanded use in environmental solutions. Major trends anticipated in the forecast period include advanced gene editing techniques, the convergence of technologies, further advancements in precision medicine, global collaboration and partnership, and the applications of synthetic biology.

The rising prevalence of chronic diseases is poised to drive the expansion of the bioengineering technology market in the future. Chronic diseases are characterized by their prolonged and persistent nature, leading to long-term health conditions. Bioengineering technology plays a crucial role in managing and treating chronic diseases due to its potential to offer innovative solutions, enhance outcomes, and improve the quality of life for patients. For instance, the National Centre for Biotechnology Information reported in January 2023 that chronic conditions are expected to increase by 99.5% from 71.522 million in 2020 to 142.66 million in 2050. Consequently, the growing prevalence of chronic diseases is fueling the growth of the bioengineering technology market.

Key players in the bioengineering technology market are focusing on developing innovative technological products, such as Mito Plus, to advance the field of regenerative medicine. Mito Plus is a cutting-edge 3D bioprinter designed to produce tissues or organs resembling natural body parts, containing living cells, using 3D printing technology. For example, Avay Biosciences Pvt. Ltd., an India-based manufacturer and service provider of 3D printers, introduced Mito Plus in November 2022. This state-of-the-art bioprinter is hailed as one of the most advanced in its price range, capable of printing a wide range of biomaterials and featuring built-in UV curing options. It also incorporates HEPA filters and temperature control, enabling cooling of the printhead and print bed by up to 4 degrees Celsius, as well as heating capabilities.

In March 2023, Ginkgo Bioworks, a US-based horizontal platform for cell programming, acquired FGen AG for an undisclosed sum. This acquisition strengthens Ginkgo's position as a leader in the bioengineering field, providing it with a robust tool for strain development and optimization across various industries. FGen AG is a Switzerland-based bioengineering company.

Major companies operating in the bioengineering technology market report are Pfizer Inc., Johnson & Johnson, Roche Holding AG, Novartis AG, Bristol-Myers Squibb Company, Thermo Fisher Scientific, Abbott Laboratories, AstraZeneca plc, Medtronic plc, Gilead Sciences Inc., Amgen Inc., Novo Nordisk A/S, Moderna Inc., Becton Dickinson (BD), Regeneron Pharmaceuticals, Inc., Biogen Inc., Vertex Pharmaceuticals Inc., Agilent Technologies, Lonza Group Ltd., Intuitive Surgical, Illumina, Inc, Bio-Rad Laboratories, Ginkgo Bioworks, Verve Therapeutics, Inc., CRISPR Therapeutics

North America was the largest region in the bioengineering technology market in 2023. The regions covered in the bioengineering technology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the bioengineering technology market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The bioengineering technology market includes revenues earned by entities service such as medical diagnostic services, pharmaceutical services, personalized medicine services, engineering, and nanotechnology in medicine services, biological data analysis services, regenerative medicine services, and health information technology. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included. The bioengineering technology market consists of sales of implantable medical devices, wearable health monitoring devices, biomedical imaging equipment, and diagnostic devices. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Bioengineering Technology Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on bioengineering technology market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for bioengineering technology ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The bioengineering technology market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

  • 1) By Product: Biomedical Engineering; Genetic Engineering; Biotechnology; Tissue Engineering; Biomechanics Engineering; Biomaterial; Biomechanical Engineering; Nano-biotechnology; Bioinformatics; Other Products
  • 2) By Technology: Nanobiotechnology; Tissue Engineering and Regeneration; DNA Sequencing; Cell-based Assays; Fermentation
  • 3) By Application: Health; Food And Agriculture; Natural Resources And Environment
  • Companies Mentioned: Pfizer Inc.; Johnson & Johnson; Roche Holding AG; Novartis AG; Bristol-Myers Squibb Company
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Bioengineering Technology Market Characteristics

3. Bioengineering Technology Market Trends And Strategies

4. Bioengineering Technology Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Bioengineering Technology Market Size and Growth

  • 5.1. Global Bioengineering Technology Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Bioengineering Technology Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Bioengineering Technology Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Bioengineering Technology Market Segmentation

  • 6.1. Global Bioengineering Technology Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Biomedical Engineering
  • Genetic Engineering
  • Biotechnology
  • Tissue Engineering
  • Biomechanics Engineering
  • Biomaterial
  • Biomechanical Engineering
  • Nano-biotechnology
  • Bioinformatics
  • Other Products
  • 6.2. Global Bioengineering Technology Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Nanobiotechnology
  • Tissue Engineering and Regeneration
  • DNA Sequencing
  • Cell-based Assays
  • Fermentation
  • 6.3. Global Bioengineering Technology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Health
  • Food And Agriculture
  • Natural Resources And Environment

7. Bioengineering Technology Market Regional And Country Analysis

  • 7.1. Global Bioengineering Technology Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Bioengineering Technology Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Bioengineering Technology Market

  • 8.1. Asia-Pacific Bioengineering Technology Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Bioengineering Technology Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Bioengineering Technology Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Bioengineering Technology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Bioengineering Technology Market

  • 9.1. China Bioengineering Technology Market Overview
  • 9.2. China Bioengineering Technology Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Bioengineering Technology Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Bioengineering Technology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Bioengineering Technology Market

  • 10.1. India Bioengineering Technology Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Bioengineering Technology Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Bioengineering Technology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Bioengineering Technology Market

  • 11.1. Japan Bioengineering Technology Market Overview
  • 11.2. Japan Bioengineering Technology Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Bioengineering Technology Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Bioengineering Technology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Bioengineering Technology Market

  • 12.1. Australia Bioengineering Technology Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Bioengineering Technology Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Bioengineering Technology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Bioengineering Technology Market

  • 13.1. Indonesia Bioengineering Technology Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Bioengineering Technology Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Bioengineering Technology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Bioengineering Technology Market

  • 14.1. South Korea Bioengineering Technology Market Overview
  • 14.2. South Korea Bioengineering Technology Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Bioengineering Technology Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Bioengineering Technology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Bioengineering Technology Market

  • 15.1. Western Europe Bioengineering Technology Market Overview
  • 15.2. Western Europe Bioengineering Technology Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Bioengineering Technology Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Bioengineering Technology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Bioengineering Technology Market

  • 16.1. UK Bioengineering Technology Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Bioengineering Technology Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Bioengineering Technology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Bioengineering Technology Market

  • 17.1. Germany Bioengineering Technology Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Bioengineering Technology Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Bioengineering Technology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Bioengineering Technology Market

  • 18.1. France Bioengineering Technology Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Bioengineering Technology Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Bioengineering Technology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Bioengineering Technology Market

  • 19.1. Italy Bioengineering Technology Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Bioengineering Technology Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Bioengineering Technology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Bioengineering Technology Market

  • 20.1. Spain Bioengineering Technology Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Bioengineering Technology Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Bioengineering Technology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Bioengineering Technology Market

  • 21.1. Eastern Europe Bioengineering Technology Market Overview
  • 21.2. Eastern Europe Bioengineering Technology Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Bioengineering Technology Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Bioengineering Technology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Bioengineering Technology Market

  • 22.1. Russia Bioengineering Technology Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Bioengineering Technology Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Bioengineering Technology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Bioengineering Technology Market

  • 23.1. North America Bioengineering Technology Market Overview
  • 23.2. North America Bioengineering Technology Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Bioengineering Technology Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Bioengineering Technology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Bioengineering Technology Market

  • 24.1. USA Bioengineering Technology Market Overview
  • 24.2. USA Bioengineering Technology Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Bioengineering Technology Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Bioengineering Technology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Bioengineering Technology Market

  • 25.1. Canada Bioengineering Technology Market Overview
  • 25.2. Canada Bioengineering Technology Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Bioengineering Technology Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Bioengineering Technology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Bioengineering Technology Market

  • 26.1. South America Bioengineering Technology Market Overview
  • 26.2. South America Bioengineering Technology Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Bioengineering Technology Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Bioengineering Technology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Bioengineering Technology Market

  • 27.1. Brazil Bioengineering Technology Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Bioengineering Technology Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Bioengineering Technology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Bioengineering Technology Market

  • 28.1. Middle East Bioengineering Technology Market Overview
  • 28.2. Middle East Bioengineering Technology Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Bioengineering Technology Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Bioengineering Technology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Bioengineering Technology Market

  • 29.1. Africa Bioengineering Technology Market Overview
  • 29.2. Africa Bioengineering Technology Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Bioengineering Technology Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Bioengineering Technology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Bioengineering Technology Market Competitive Landscape And Company Profiles

  • 30.1. Bioengineering Technology Market Competitive Landscape
  • 30.2. Bioengineering Technology Market Company Profiles
    • 30.2.1. Pfizer Inc.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Johnson & Johnson
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Roche Holding AG
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Novartis AG
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Bristol-Myers Squibb Company
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Bioengineering Technology Market Other Major And Innovative Companies

  • 31.1. Thermo Fisher Scientific
  • 31.2. Abbott Laboratories
  • 31.3. AstraZeneca plc
  • 31.4. Medtronic plc
  • 31.5. Gilead Sciences Inc.
  • 31.6. Amgen Inc.
  • 31.7. Novo Nordisk A/S
  • 31.8. Moderna Inc.
  • 31.9. Becton Dickinson (BD)
  • 31.10. Regeneron Pharmaceuticals, Inc.
  • 31.11. Biogen Inc.
  • 31.12. Vertex Pharmaceuticals Inc.
  • 31.13. Agilent Technologies
  • 31.14. Lonza Group Ltd.
  • 31.15. Intuitive Surgical

32. Global Bioengineering Technology Market Competitive Benchmarking

33. Global Bioengineering Technology Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Bioengineering Technology Market

35. Bioengineering Technology Market Future Outlook and Potential Analysis

  • 35.1 Bioengineering Technology Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Bioengineering Technology Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Bioengineering Technology Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer